Replies to post #96922 on Biotech Values

[DewDiligence]

…the pre-existing dominant strain in a patient's quasispecies can sometimes be the V36M or R155K variant (that has a reduced response to telaprevir), and even if a variant [is] present at low prevalence within the quasispecies it can quickly become the dominant sequence if it offers a selective advantage.

What is the connection, if any, between the above and the Survival of the Flattest phenomenon? T.i.a.